Brief: Palisade Bio Reports Data Demonstrating Pde4b Expression In Patient Cohorts Could Be Utilized As A Potential Marker For Patient Stratification
Palisade Bio Inc PALI.O :
* PALISADE BIO REPORTS DATA DEMONSTRATING PDE4B EXPRESSION
IN
PATIENT COHORTS COULD BE UTILIZED AS A POTENTIAL MARKER FOR
PATIENT STRATIFICATION
* PALISADE BIO INC - PHASE 1 STUDY OF PALI-2108 FOR UC TO
COMMENCE
BEFORE YEAR-END
Source text for Eikon: ID:nGNXc6MGPr
Further company coverage: PALI.O
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing